AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

SLXN · NASDAQ · Biotechnology

Silexion Therapeutics (SLXN)

Develops RNA-targeting treatment candidates for KRAS-mutated pancreatic cancer.

$0.3515

Pre-market+0.00 (+0.34%)

At close$0.3503(−5.35%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions7 holders · as of Mar 31, 2026	0.07%	3.6K shares
Insiders9 holders · as of Jun 8, 2026	1.65%	91.5K shares
Otherremainder	98.28%	5.47M shares

5.56M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (5.56M in the company's Sep 3, 2026 report, 419.0K elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Ilan LevinInsiderdirector, 10 percent owner	0.82%	45,697	Form 4filed Jan 27, 2026 ↗
Ilan HadarInsiderdirector, officer: Chairman and CEO	0.30%	16,547	Form 4filed Jun 8, 2026 ↗
Hadar Mirit HorenshteinInsiderofficer: CFO and Secretary	0.23%	12,515	Form 4filed Jun 8, 2026 ↗
Mitchell ShirvanInsiderofficer: CSO and CDO	0.16%	8,789	Form 4filed Jun 8, 2026 ↗
Avner LushiInsiderdirector	0.05%	2,540	Form 4filed Feb 23, 2026 ↗
Shlomo NoyInsiderdirector	0.05%	2,540	Form 4filed Feb 25, 2026 ↗
Citadel Advisors LLCInstitution	0.04%	20,926	13Fas of Mar 31, 2026
Two Sigma Securities, LLCInstitution	0.02%	11,657	13Fas of Mar 31, 2026
Ruth AlonInsiderdirector	0.02%	1,023	Form 4filed Feb 23, 2026 ↗
Dror Yosef AbramovInsiderdirector	0.02%	1,018	Form 4filed Feb 23, 2026 ↗
Amnon PeledInsiderdirector	0.01%	824	Form 4filed Feb 23, 2026 ↗
Montag A & Associates IncInstitution	0.01%	3,000	13Fas of Mar 31, 2026
UBS Group AGInstitution	0.00%	517	13Fas of Mar 31, 2026
Pflug Koory, LLCInstitution	0.00%	333	13Fas of Mar 31, 2026
Jones Financial Companies LLLPInstitution	0.00%	26	13Fas of Mar 31, 2026
Sbi Securities Co., Ltd.Institution	0.00%	20	13Fas of Mar 31, 2026
Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP)Institution	—13.80% of class, as filed	—	13Dfiled Nov 20, 2024 ↗
Lincoln Alternative Strategies LLCStrategic	—6.18% of class, as filed	—	13Gfiled Sep 15, 2025 ↗
Moringa Sponsor, LPInstitution	—25.00% of class, as filed	—	13Dfiled Aug 19, 2026 ↗
Wildcat Capital Management, LLC^1,2Strategic10 percent owner	0.01%	756	Form 4filed Aug 15, 2024 ↗
Ilan Shiloah¹Insiderdirector	0.01%	287	Form 4filed Aug 15, 2024 ↗

Last filed Aug 15, 2024; leaving the company requires no filing. Not in the bar.
Reported at 1.30% on Jun 26, 2025, under the 5% line, so no further filing is required.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

7 holders · 36.5K shares · 1 new position · 2 increased · 2 reduced · 0 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Citadel Advisors LLC	20.9K	0.38%	+8.7K	May 15, 2026
Two Sigma Securities, LLC	11.7K	0.21%	+11.7Knew	May 15, 2026
Montag A & Associates Inc	3.0K	0.05%	0	Apr 29, 2026
UBS Group AG	517	0.01%	−1.2K	May 5, 2026
Pflug Koory, LLC	333	0.01%	0	Apr 22, 2026
Jones Financial Companies LLLP	26	0.00%	0	May 15, 2026
Sbi Securities Co., Ltd.	20	0.00%	−1.0K	Apr 28, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Form	Filed
Moringa Sponsor, LPincl. Ilan Levin, Moringa Partners Ltd	25.00%	13D	Aug 19, 2026 ↗
Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP)incl. Shlomo Noy, Avner Lushi	13.80%	13D	Nov 20, 2024 ↗
Lincoln Alternative Strategies LLC	6.18%	13G	Sep 15, 2025 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Mar 26, 2026	Mitchell Shirvanofficer: CSO and CDO	Sale	22,818	$1.36	27,889

CongressHouse and Senate disclosures

Not reported.